Results 221 to 230 of about 117,898 (292)

Longitudinal analysis of usage and public awareness of tyrosine kinase inhibitors for CML. [PDF]

Front Oncol
Schroer AE, Javadi T, Mehta A, Torlak F, McFarland JR, Kumar G, da Silva AL, Benjamin J, Choudhary MM, Sadeghi A, le Coutre P, Blaha MJ, Berning P, Dzaye O.   +13 more
europepmc   +1 more source

Kinetics of BCR-ABL Transcripts in Imatinib Mesylate treated Chronic Phase CML (CPCML), A Predictor of Response and Progression Free Survival.

, 2009
Hossam K. Mahmoud, Yasser El Nahas, Mohamad Abdel Moaty, Raafat Abdel Fattah, Mohamad El Emary, Wafaa El Metnawy   +5 more
openalex   +1 more source

Tyrosine Kinase Inhibitors as Risk Factors for Cerebral Vascular Disease: Report of Two Cases and Literature Review. [PDF]

Case Rep Neurol Med
Papatolis E, Kalampokini S, Liouta E, Foinitsis S, Hatjiharissi E, Kourti O, Tegos T, Arnaoutoglou M, Kimiskidis VK.   +8 more
europepmc   +1 more source

Abstracts

Cancer Science, Volume 117, Issue S1, Page 1-2148, January 2026.
wiley   +1 more source

Recurrent gastrointestinal stromal tumor with c-KIT double exon mutations: A rare case report. [PDF]

Cytojournal
Zhu N, Li N, Song L, Pan Y, Zhang H, Wang W, Li J, Yang P, Yu G.   +8 more
europepmc   +1 more source

Comparative efficacy of neoadjuvant imatinib therapy in gastric versus rectal gastrointestinal stromal tumors: a two-center retrospective cohort study. [PDF]

BMC Gastroenterol
Chen JH, Cai ZM, Yang ZR, Lin T, Hong SC, Su XC, Lin YM, Lin L, Ye ZS, Zhou YJ.   +9 more
europepmc   +1 more source

Mutational landscape of gastrointestinal stromal tumors using next-generation sequencing of a 73-gene panel. [PDF]

World J Surg Oncol
Wang C, Cheng B, Yang S, Yin H, Xiong Y, Chen R, Wu Y, Wang C, Wang B, Gao Z, Ye Y.   +10 more
europepmc   +1 more source

Efficacy of erlotinib and imatinib in a patient with a rectal gastrointestinal stromal tumor and synchronous pulmonary adenocarcinoma: A case report

, 2016
Takanori Miyoshi, Riho Mori, Sachiko Amano, Hiroyuki Sumitomo, Mariko Aoyama, Seiya Inoue, Naoki Hino, Daisuke Wada   +7 more
openalex   +2 more sources

Design, Synthesis, and Biological Evaluation of Efflux-Resistant Imatinib Derivatives. [PDF]

J Med Chem
Chowdhury MM, Pretheshan P, Chowdhury NS, Andriollo P, Shah AJ, Forbes B, Pepper C, Rahman KM.   +7 more
europepmc   +1 more source

<i>FGFR2</i> fusions as novel oncogenic drivers in gastrointestinal stromal tumors: Two case reports and review of literature. [PDF]

World J Gastrointest Oncol
Hong YY, Shou CH, Yang WL, Wang XD, Zhang Q, Liu XS, Yu JR.   +6 more
europepmc   +1 more source